1. |
Farber BF, Moellering RC Jr. Retrospective study of the toxicity of preparations of vancomycin from 1974 to 1981[J]. Antimicrob Agents Chemother, 1983, 23(1): 138-141.
|
2. |
Morris A, Ward C. High incidence of vancomycin-associated leucopenia and neutropenia in a cardiothoracic surgical unit[J]. J Infect, 1991, 22(3): 217-223.
|
3. |
Pai MP, Mercier RC, Koster SA. Epidemiology of vancomycin-induced neutropenia in patients receiving home intravenous infusion therapy[J]. Ann Pharmacother, 2006, 40(2): 224-228.
|
4. |
Segarra-Newnham M, Tagoff SS. Probable vancomycin-induced neutropenia[J]. Ann Pharmacother, 2004, 38(11): 1855-1859.
|
5. |
LeFrock J, Ristuccia A. Teicoplanin in the treatment of bone and joint infections: an open study[J]. J Infect Chemo-ther, 1999, 5(1): 32-39.
|
6. |
Black E, Lau TT, Ensom MH. Vancomycin-induced neutropenia: is it dose-or duration-related?[J].Ann Pharmacother, 2011, 45(5): 629-638.
|
7. |
杨新云, 钟淑卿, 肖丽婷. 万古霉素相关白细胞减少[J]. 药物不良反应杂志, 2009, 11(5): 373-374.
|
8. |
卢国良. 万古霉素致严重白细胞减少[J]. 药物不良反应杂志, 2007, 9(2): 136.
|